SETROZ 2.5MG
SETROZ (Letrozole 2.5 mg Tablet) is an ovulation induction therapy specially formulated for women with PCOS, anovulation, and infertility management. It is widely recommended as a first-line treatment option for improving ovulation and increasing pregnancy outcomes in assisted reproductive care.
Clinical Insights:-
PCOS affects a significant percentage of reproductive-age women, and anovulation remains one of the leading causes of infertility. Clinical practice supports Letrozole as a preferred ovulation induction therapy, especially in women showing clomiphene resistance or irregular ovulation patterns.
Key Benefits
- Supports effective ovulation induction
- Improves pregnancy & live birth outcomes in PCOS
- Endometrium-friendly formulation
- Lower risk of OHSS & multiple gestation
- Well tolerated with minimal side effects
- Recommended in clomiphene-resistant infertility
- Used in IVF ovulation induction protocols
Why Choose SETROZ?
Indications
SETROZ is indicated in women with:
- PCOS & anovulation
- Clomiphene-resistant infertility
- Ovulation disorders
- Metabolic infertility
- Unexplained infertility (IUI cycles)
- Assisted reproductive protocols
Dosage Information
| Condition | Dose | Duration |
|---|---|---|
| PCOS Ovulation Induction | 2.5 mg OD | Day 2–6 Cycle |
| Unexplained Infertility (IUI Cycles) | 5 mg OD | Day 2–6 Cycle |
Safety Information
- Use only under medical supervision
- Store in a cool & dry place
- Keep away from children
- Do not exceed prescribed dosage
FAQs
-
What is SETROZ used for?
SETROZ is used for ovulation induction in women with PCOS, anovulation, and infertility management.
-
Is SETROZ useful in IVF protocols?
Yes, it is commonly used in IVF and assisted reproduction protocols for ovulation support.
-
What makes SETROZ different?
SETROZ provides effective ovulation induction with better endometrial support and lower risk of multiple gestation & OHSS.
